Kunio Sugahara Selected Research

beta-MSH

7/2009

Corticotropin-releasing factor is a downstream mediator of the beta-melanocyte-stimulating hormone-induced anorexigenic pathway in chicks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kunio Sugahara Research Topics

Disease

6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2005
5	Body Weight (Weight, Body) 01/2013 - 02/2002
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015 - 12/2005
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2019
2	Arthritis (Polyarthritis) 12/2013 - 01/2008
2	Experimental Arthritis 12/2013 - 01/2008
2	Rheumatoid Arthritis 12/2013 - 01/2008
2	Hyperglycemia 11/2012 - 04/2007
1	Eosinophilia 01/2021
1	Lymphadenopathy 01/2021
1	Immunoglobulin G4-Related Disease 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Sclerosis 01/2019
1	Lupus Nephritis 01/2019
1	Colitis 01/2019
1	Bradycardia 01/2017
1	Neoplasms (Cancer) 03/2016
1	Multiple Sclerosis 08/2015
1	Anorexia 11/2012
1	Hypoglycemia (Reactive Hypoglycemia) 07/2009
1	Stroke (Strokes) 01/2008
1	Thymoma (Thymic Carcinoma) 12/2006
1	Inflammation (Inflammations) 12/2005
1	Demyelinating Diseases (Demyelinating Disease) 12/2005

Drug/Important Bio-Agent (IBA)

5	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017 - 12/2005
4	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019 - 03/2011
4	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 12/2005
4	Messenger RNA (mRNA)IBA 12/2013 - 12/2006
3	InterleukinsIBA 01/2022 - 12/2013
3	amiselimodIBA 01/2019 - 01/2017
3	Therapeutic UsesIBA 01/2019 - 12/2005
3	Leucine (L-Leucine)FDA Link 01/2013 - 02/2002
3	Glucose (Dextrose)FDA LinkGeneric 11/2012 - 04/2007
2	InterferonsIBA 01/2022 - 03/2011
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
2	CytokinesIBA 12/2013 - 01/2008
2	Glucagon (Glukagon)FDA Link 11/2012 - 04/2007
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Chemokine CCL26IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2016
1	Interleukin-17 (Interleukin 17)IBA 12/2013
1	Interleukin-15 (Interleukin 15)IBA 12/2013
1	Collagen Type II (Type II Collagen)IBA 12/2013
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2013
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 11/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2012
1	Phentolamine (Z-Max)FDA LinkGeneric 11/2012
1	Corticotropin-Releasing HormoneIBA 11/2012
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2012
1	beta-MSHIBA 07/2009
1	OrexinsIBA 07/2009
1	EdaravoneIBA 01/2008
1	Free Radical ScavengersIBA 01/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2008
1	NF-kappa B (NF-kB)IBA 01/2008
1	Neuropeptide YIBA 11/2007
1	Dihydrotachysterol (AT 10)IBA 12/2006
1	Interferon-betaIBA 12/2005
1	AntigensIBA 12/2005

Therapy/Procedure

1	Oral Administration 12/2013